AmideBio LLC has a total of 22 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are ARIZEKE PHARMACEUTICALS INC, AVIDIS SA and CYTRAN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | United Kingdom | 2 | |
#5 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Stowell Michael H B | 17 |
#2 | Plam Mikhail | 17 |
#3 | Peng Yanyu | 12 |
#4 | Eisenberg Stephen | 3 |
#5 | Rosendahl Mary S | 3 |
#6 | Mikhail Plam | 2 |
#7 | Yanyu Peng | 1 |
#8 | Michael Stowell | 1 |
#9 | Michael H B Stowell | 1 |
Publication | Filing date | Title |
---|---|---|
WO2018187147A1 | Glucose-responsive insulin analogs and methods of use thereof | |
WO2017214543A1 | Glucagon analogs and methods of use thereof | |
EP3429612A1 | Methods for producing peptides and uses thereof | |
WO2014172488A2 | Chemically and thermodynamically stable insulin analogues and improved methods for their production | |
US2013096057A1 | Chemically and thermodynamically stable insulin analogues and improved methods for their production | |
WO2012012352A2 | Modified peptides and proteins |